
    
      The study was conducted as an open label, balanced, randomised, two-treatment, two-period,
      two-sequence, single-dose, crossover , bioequivalence study on glimepiride comparing
      glimepiride 1mg tablets of Ranbaxy laboratories limited with Amaryl 1mg tablets of in
      healthy, adult, human, subjects under fasting conditions.

      A total of 32 subjects were entered into this study and 31 subjects completed the study.
    
  